Bio Green Med Solution, Inc. filed a current report on November 20, 2026, disclosing the results of a special shareholder meeting held on November 19, 2026, at which shareholders voted on five proposals related to a business combination with Future NRG Sdn Bhd.

Key Highlights

  • Quorum reached: 4,935,383 shares were present or represented by proxy, constituting approximately 74.52% of the 6,622,794 shares entitled to vote as of the October 5, 2026 record date.
  • Share issuance approved: Proposal 1, approving issuance of common stock to Selling Shareholders under the Business Combination Agreement with Future NRG dated June 4, 2026, passed with 4,178,146 votes (63.1%) in favor.
  • Nasdaq compliance vote passed: Proposal 2, covering the issuance of more than 20% of outstanding shares and change of control under Nasdaq Listing Rules 5635(a) and 5635(b), passed with 4,177,953 votes (63.1%) for.
  • Authorized shares increased: Proposal 3 to amend the certificate of incorporation to authorize up to 3,000,000,000 shares of common stock passed with 4,844,487 votes (73.1%) in favor.
  • Reverse stock split authorized: Proposal 4 authorizing a reverse stock split at a ratio between 1:4 and 1:16, to be set by the Board, passed with 4,894,944 votes (73.9%) for.
  • Future financing approved: Proposal 5 allowing issuance and sale of shares, warrants, and other securities over a 24-month period following the transaction passed with 4,177,871 votes (63.1%) in favor.

Bio Green Med Solution Special Meeting: All Five Proposals Approved

According to the filing, Bio Green Med Solution, Inc. (NASDAQ:BGMS) held a virtual special meeting of shareholders on November 19, 2026, via live audio webcast. The meeting was called in connection with a Business Combination Agreement between BGMS, Future NRG Sdn Bhd., and the Selling Shareholders, originally dated June 4, 2026, and described in a definitive proxy statement filed with the SEC on October 9, 2026. The record date for the meeting was October 5, 2026, at which point 6,622,794 shares of common stock, par value $0.001 per share, were issued and outstanding.

The filing reports that all five proposals were approved by shareholders. Proposals 1, 2, and 5, each related to share issuances in connection with the transaction and future financing, each received approximately 63.1% of total votes entitled to be cast. Each of these three proposals carried 690,759 broker non-votes, representing 10.4% of eligible votes. Proposals 3 and 4, which required no Nasdaq discretionary vote classification, carried no broker non-votes, and both passed with over 73% of total eligible votes in favor.

Proposal 3 would amend the Amended and Restated Certificate of Incorporation to raise the authorized share count to 3,000,000,000 shares. Proposal 4 would allow the Board of Directors to effect a reverse stock split at a ratio it selects within the range of not less than 1:4 and not more than 1:16. Proposal 5 covers potential issuance and sale of shares, warrants, and other linked securities during the 24-month period following completion of the transaction, subject to applicable Delaware law, SEC rules, and Nasdaq requirements, according to the filing. The report was signed by Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director, on November 20, 2026.

What Was Disclosed

Bio Green Med Solution, Inc. reported the final voting results from its November 19, 2026 special shareholder meeting, at which all five proposals related to its business combination with Future NRG Sdn Bhd. and associated share issuances were approved by shareholders.